In focus · trending topic

NASDAQ: LGND

2 stories · following the connections

Deadline in Lawsuit for Investors in shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) announced by Shareholders Foundation

By Nasdaq OMXJan 11, 2017, 6:20 PM UTC

Lawsuit for Investors in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) over alleged Violations of Securities Laws announced by Shareholders Foundation

By Nasdaq OMXNov 29, 2016, 6:35 PM UTC